Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | AAAS CL E G H | 8086 | 13666 | OMIM:231550 | Achalasia-Addisonianism-Alacrima syndrome | | | | 57 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | ABCD1 CL E G H | 215 | 61 | ORPHA:139396 | X-linked cerebral adrenoleukodystrophy | | | | 135 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | AIRE CL E G H | 326 | 360 | ORPHA:3453 | Autoimmune polyendocrinopathy type 1 | | | | 92 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | AKT1 CL E G H | 207 | 391 | ORPHA:2495 | Meningioma | | | | 54 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | ARMC5 CL E G H | 79798 | 25781 | OMIM:615954 | ACTH-independent macronodular adrenal hyperplasia 2 | | | | 7 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | ARMC5 CL E G H | 79798 | 25781 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 7 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | ATRX CL E G H | 546 | 886 | ORPHA:96253 | Cushing disease | | | | 169 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | BAP1 CL E G H | 8314 | 950 | ORPHA:2495 | Meningioma | | | | 184 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | BRAF CL E G H | 673 | 1097 | ORPHA:96253 | Cushing disease | | | | 276 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | CDH23 CL E G H | 64072 | 13733 | ORPHA:96253 | Cushing disease | | | | 636 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | CDKN1A CL E G H | 1026 | 1784 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | 2 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | 102 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:276152 | Multiple endocrine neoplasia type 4 | | | | 102 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | CDKN2A CL E G H | 1029 | 1787 | ORPHA:1501 | Adrenocortical carcinoma | | | | 289 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | CDKN2B CL E G H | 1030 | 1788 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | 1 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | CDKN2C CL E G H | 1031 | 1789 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:1501 | Adrenocortical carcinoma | | | | 88 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:168558 | 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency | | | | 31 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:289548 | Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency | | | | 31 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | CYP11B1 CL E G H | 1584 | 2591 | OMIM:202010 | Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency | | | | 112 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | CYP11B1 CL E G H | 1584 | 2591 | ORPHA:90795 | Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency | | | | 112 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | CYP11B2 CL E G H | 1585 | 2592 | ORPHA:556030 | Early-onset familial hypoaldosteronism | | | | 73 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | CYP17A1 CL E G H | 1586 | 2593 | ORPHA:90793 | Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency | | | | 53 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | GATB CL E G H | 5188 | 8849 | OMIM:618838 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 41; COXPD41 | | | | | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | GATC CL E G H | 283459 | 25068 | OMIM:618839 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42; COXPD42 | | | | 1 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | GLI3 CL E G H | 2737 | 4319 | OMIM:146510 | Pallister-Hall syndrome | | | | 270 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | GNAS CL E G H | 2778 | 4392 | OMIM:219080 | ACTH-independent macronodular adrenal hyperplasia | | | | 101 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | GNAS CL E G H | 2778 | 4392 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 101 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | GNAS CL E G H | 2778 | 4392 | ORPHA:562 | McCune-Albright syndrome | | | | 101 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | GNAS CL E G H | 2778 | 4392 | OMIM:174800 | McCune-Albright syndrome, somatic, mosaic | | | | 101 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | HSD11B2 CL E G H | 3291 | 5209 | ORPHA:320 | Apparent mineralocorticoid excess | HP:0040282 - Frequent | | | 14 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | HSD3B2 CL E G H | 3284 | 5218 | ORPHA:90791 | Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency | | | | 34 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | HTR1A CL E G H | 3350 | 5286 | OMIM:614674 | Periodic fever, menstrual cycle-dependent | | | | 2 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:79644 | Autosomal recessive hyperinsulinism due to Kir6.2 deficiency | | | | 127 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | MC2R CL E G H | 4158 | 6930 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 94 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | MC2R CL E G H | 4158 | 6930 | OMIM:202200 | Glucocorticoid deficiency 1 | | | | 94 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | MEN1 CL E G H | 4221 | 7010 | OMIM:131100 | Multiple endocrine neoplasia 1 | | | | 462 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | MEN1 CL E G H | 4221 | 7010 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | 462 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | MRAP CL E G H | 56246 | 1304 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 26 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | MRAP CL E G H | 56246 | 1304 | OMIM:607398 | Glucocorticoid deficiency 2 | | | | 26 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | NF2 CL E G H | 4771 | 7773 | ORPHA:2495 | Meningioma | | | | 220 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | NFKB2 CL E G H | 4791 | 7795 | ORPHA:293978 | Deficiency in anterior pituitary function-variable immunodeficiency syndrome | | | | 11 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | NNT CL E G H | 23530 | 7863 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 13 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | NR0B1 CL E G H | 190 | 7960 | OMIM:300200 | Adrenal hypoplasia, congenital | | | | 48 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:96253 | Cushing disease | | | | 79 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:786 | Generalized glucocorticoid resistance syndrome | | | | 79 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | PCSK1 CL E G H | 5122 | 8743 | OMIM:600955 | Proprotein convertase 1/3 deficiency | | | | 65 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | PDE11A CL E G H | 50940 | 8773 | ORPHA:1359 | Carney complex | | | | 13 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | PDE11A CL E G H | 50940 | 8773 | OMIM:610475 | Pigmented nodular adrenocortical disease, primary, 2 | | | | 13 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | PDE11A CL E G H | 50940 | 8773 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 13 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | PDE8B CL E G H | 8622 | 8794 | OMIM:614190 | Pigmented nodular adrenocortical disease, primary, 3 | | | | 75 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | PDE8B CL E G H | 8622 | 8794 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 75 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | PDGFB CL E G H | 5155 | 8800 | ORPHA:2495 | Meningioma | | | | 9 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:2495 | Meningioma | | | | 162 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | POR CL E G H | 5447 | 9208 | ORPHA:95699 | Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency | | | | 76 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | PRKACA CL E G H | 5566 | 9380 | OMIM:615830 | Pigmented nodular adrenocortical disease, primary, 4 | | | | 2 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | PRKACA CL E G H | 5566 | 9380 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 2 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:1501 | Adrenocortical carcinoma | | | | 134 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:1359 | Carney complex | | | | 134 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | PRKAR1A CL E G H | 5573 | 9388 | OMIM:610489 | Pigmented nodular adrenocortical disease, primary, 1 | | | | 134 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 134 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | QRSL1 CL E G H | 55278 | 21020 | OMIM:618835 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40; COXPD40 | | | | | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | RET CL E G H | 5979 | 9967 | OMIM:171400 | Multiple endocrine neoplasia, type IIA | | | | 572 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | SERPINA6 CL E G H | 866 | 1540 | OMIM:611489 | Corticosteroid-binding globulin deficiency | | | | 4 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:2495 | Meningioma | | | | 87 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | SMARCE1 CL E G H | 6605 | 11109 | ORPHA:2495 | Meningioma | | | | 47 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | SMO CL E G H | 6608 | 11119 | ORPHA:2495 | Meningioma | | | | 22 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | STAR CL E G H | 6770 | 11359 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 45 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | SUFU CL E G H | 51684 | 16466 | ORPHA:2495 | Meningioma | | | | 124 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | TBX19 CL E G H | 9095 | 11596 | OMIM:201400 | Acth deficiency, isolated | | | | 57 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | TBX19 CL E G H | 9095 | 11596 | ORPHA:199296 | Congenital isolated ACTH deficiency | | | | 57 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | TERT CL E G H | 7015 | 11730 | ORPHA:1501 | Adrenocortical carcinoma | | | | 238 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | TERT CL E G H | 7015 | 11730 | ORPHA:2495 | Meningioma | | | | 238 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | TP53 CL E G H | 7157 | 11998 | ORPHA:1501 | Adrenocortical carcinoma | | | | 911 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | TP53 CL E G H | 7157 | 11998 | ORPHA:96253 | Cushing disease | | | | 911 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | TRAF7 CL E G H | 84231 | 20456 | ORPHA:2495 | Meningioma | | | | | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | TXNRD2 CL E G H | 10587 | 18155 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 85 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | TXNRD2 CL E G H | 10587 | 18155 | OMIM:617825 | GLUCOCORTICOID DEFICIENCY 5; GCCD5 | | | | 85 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | USP48 CL E G H | 84196 | 18533 | ORPHA:96253 | Cushing disease | | | | 1 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | USP8 CL E G H | 9101 | 12631 | ORPHA:96253 | Cushing disease | | | | 7 | | |
HP:0011731 | HP:0011731 | Abnormality of circulating cortisol level | 0 | ZNRF3 CL E G H | 84133 | 18126 | ORPHA:1501 | Adrenocortical carcinoma | | | | | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | AAAS CL E G H | 8086 | 13666 | OMIM:231550 | Achalasia-Addisonianism-Alacrima syndrome | . | | | 57 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | ABCD1 CL E G H | 215 | 61 | ORPHA:139396 | X-linked cerebral adrenoleukodystrophy | HP:0040281 - Very frequent | | | 135 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | AIRE CL E G H | 326 | 360 | ORPHA:3453 | Autoimmune polyendocrinopathy type 1 | HP:0040281 - Very frequent | | | 92 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | AKT1 CL E G H | 207 | 391 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 54 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | ARMC5 CL E G H | 79798 | 25781 | OMIM:615954 | ACTH-independent macronodular adrenal hyperplasia 2 | | | | 7 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | ARMC5 CL E G H | 79798 | 25781 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 7 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | ARMC5 CL E G H | 79798 | 25781 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 7 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | ATRX CL E G H | 546 | 886 | ORPHA:96253 | Cushing disease | | | | 169 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | ATRX CL E G H | 546 | 886 | ORPHA:96253 | Cushing disease | | | | 169 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | BAP1 CL E G H | 8314 | 950 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 184 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | BRAF CL E G H | 673 | 1097 | ORPHA:96253 | Cushing disease | | | | 276 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | BRAF CL E G H | 673 | 1097 | ORPHA:96253 | Cushing disease | | | | 276 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | CDH23 CL E G H | 64072 | 13733 | ORPHA:96253 | Cushing disease | | | | 636 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | CDH23 CL E G H | 64072 | 13733 | ORPHA:96253 | Cushing disease | | | | 636 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | CDKN1A CL E G H | 1026 | 1784 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 2 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 102 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:276152 | Multiple endocrine neoplasia type 4 | HP:0040283 - Occasional | | | 102 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | CDKN2A CL E G H | 1029 | 1787 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 289 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | CDKN2A CL E G H | 1029 | 1787 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 289 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | CDKN2B CL E G H | 1030 | 1788 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 1 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | CDKN2C CL E G H | 1031 | 1789 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 88 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 88 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:168558 | 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency | HP:0040281 - Very frequent | | | 31 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:289548 | Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency | HP:0040281 - Very frequent | | | 31 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | CYP11B1 CL E G H | 1584 | 2591 | OMIM:202010 | Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency | | | | 112 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | CYP11B1 CL E G H | 1584 | 2591 | ORPHA:90795 | Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency | HP:0040281 - Very frequent | | | 112 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | CYP11B2 CL E G H | 1585 | 2592 | ORPHA:556030 | Early-onset familial hypoaldosteronism | | | | 73 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | CYP17A1 CL E G H | 1586 | 2593 | ORPHA:90793 | Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency | HP:0040282 - Frequent | | | 53 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | GATB CL E G H | 5188 | 8849 | OMIM:618838 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 41; COXPD41 | | | | | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | GATC CL E G H | 283459 | 25068 | OMIM:618839 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42; COXPD42 | | | | 1 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | GLI3 CL E G H | 2737 | 4319 | OMIM:146510 | Pallister-Hall syndrome | | | | 270 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | GNAS CL E G H | 2778 | 4392 | OMIM:219080 | ACTH-independent macronodular adrenal hyperplasia | . | | | 101 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | GNAS CL E G H | 2778 | 4392 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 101 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | GNAS CL E G H | 2778 | 4392 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 101 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | GNAS CL E G H | 2778 | 4392 | ORPHA:562 | McCune-Albright syndrome | HP:0040284 - Very rare | | | 101 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | GNAS CL E G H | 2778 | 4392 | OMIM:174800 | McCune-Albright syndrome, somatic, mosaic | . | | | 101 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | HSD3B2 CL E G H | 3284 | 5218 | ORPHA:90791 | Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency | HP:0040282 - Frequent | | | 34 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | HTR1A CL E G H | 3350 | 5286 | OMIM:614674 | Periodic fever, menstrual cycle-dependent | HP:0040283 - Occasional | | | 2 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:79644 | Autosomal recessive hyperinsulinism due to Kir6.2 deficiency | | | | 127 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | MC2R CL E G H | 4158 | 6930 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040280 - Obligate | | | 94 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | MC2R CL E G H | 4158 | 6930 | OMIM:202200 | Glucocorticoid deficiency 1 | . | | | 94 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | MEN1 CL E G H | 4221 | 7010 | OMIM:131100 | Multiple endocrine neoplasia 1 | . | | | 462 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | MEN1 CL E G H | 4221 | 7010 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 462 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | MRAP CL E G H | 56246 | 1304 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040280 - Obligate | | | 26 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | MRAP CL E G H | 56246 | 1304 | OMIM:607398 | Glucocorticoid deficiency 2 | . | | | 26 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | NF2 CL E G H | 4771 | 7773 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 220 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | NFKB2 CL E G H | 4791 | 7795 | ORPHA:293978 | Deficiency in anterior pituitary function-variable immunodeficiency syndrome | HP:0040281 - Very frequent | | | 11 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | NNT CL E G H | 23530 | 7863 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040280 - Obligate | | | 13 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | NR0B1 CL E G H | 190 | 7960 | OMIM:300200 | Adrenal hypoplasia, congenital | . | | | 48 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:96253 | Cushing disease | | | | 79 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:96253 | Cushing disease | | | | 79 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:786 | Generalized glucocorticoid resistance syndrome | HP:0040281 - Very frequent | | | 79 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | PCSK1 CL E G H | 5122 | 8743 | OMIM:600955 | Proprotein convertase 1/3 deficiency | . | | | 65 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | PDE11A CL E G H | 50940 | 8773 | ORPHA:1359 | Carney complex | HP:0040282 - Frequent | | | 13 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | PDE11A CL E G H | 50940 | 8773 | OMIM:610475 | Pigmented nodular adrenocortical disease, primary, 2 | . | | | 13 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | PDE11A CL E G H | 50940 | 8773 | OMIM:610475 | Pigmented nodular adrenocortical disease, primary, 2 | . | | | 13 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | PDE11A CL E G H | 50940 | 8773 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 13 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | PDE11A CL E G H | 50940 | 8773 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 13 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | PDE8B CL E G H | 8622 | 8794 | OMIM:614190 | Pigmented nodular adrenocortical disease, primary, 3 | . | | | 75 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | PDE8B CL E G H | 8622 | 8794 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 75 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | PDE8B CL E G H | 8622 | 8794 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 75 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | PDGFB CL E G H | 5155 | 8800 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 9 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 162 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | POR CL E G H | 5447 | 9208 | ORPHA:95699 | Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency | HP:0040282 - Frequent | | | 76 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | PRKACA CL E G H | 5566 | 9380 | OMIM:615830 | Pigmented nodular adrenocortical disease, primary, 4 | . | | | 2 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | PRKACA CL E G H | 5566 | 9380 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 2 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | PRKACA CL E G H | 5566 | 9380 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 2 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 134 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 134 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:1359 | Carney complex | HP:0040282 - Frequent | | | 134 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | PRKAR1A CL E G H | 5573 | 9388 | OMIM:610489 | Pigmented nodular adrenocortical disease, primary, 1 | . | | | 134 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | PRKAR1A CL E G H | 5573 | 9388 | OMIM:610489 | Pigmented nodular adrenocortical disease, primary, 1 | . | | | 134 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 134 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 134 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | QRSL1 CL E G H | 55278 | 21020 | OMIM:618835 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40; COXPD40 | | | | | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | RET CL E G H | 5979 | 9967 | OMIM:171400 | Multiple endocrine neoplasia, type IIA | . | | | 572 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | SERPINA6 CL E G H | 866 | 1540 | OMIM:611489 | Corticosteroid-binding globulin deficiency | | | | 4 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 87 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | SMARCE1 CL E G H | 6605 | 11109 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 47 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | SMO CL E G H | 6608 | 11119 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 22 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | STAR CL E G H | 6770 | 11359 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040280 - Obligate | | | 45 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | SUFU CL E G H | 51684 | 16466 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 124 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | TBX19 CL E G H | 9095 | 11596 | OMIM:201400 | Acth deficiency, isolated | . | | | 57 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | TBX19 CL E G H | 9095 | 11596 | ORPHA:199296 | Congenital isolated ACTH deficiency | HP:0040280 - Obligate | | | 57 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | TERT CL E G H | 7015 | 11730 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 238 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | TERT CL E G H | 7015 | 11730 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 238 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | TERT CL E G H | 7015 | 11730 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 238 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | TP53 CL E G H | 7157 | 11998 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 911 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | TP53 CL E G H | 7157 | 11998 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 911 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | TP53 CL E G H | 7157 | 11998 | ORPHA:96253 | Cushing disease | | | | 911 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | TP53 CL E G H | 7157 | 11998 | ORPHA:96253 | Cushing disease | | | | 911 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | TRAF7 CL E G H | 84231 | 20456 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | TXNRD2 CL E G H | 10587 | 18155 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040280 - Obligate | | | 85 | | |
HP:0011731 | HP:0008163 | Decreased circulating cortisol level | 1 | TXNRD2 CL E G H | 10587 | 18155 | OMIM:617825 | GLUCOCORTICOID DEFICIENCY 5; GCCD5 | | | | 85 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | USP48 CL E G H | 84196 | 18533 | ORPHA:96253 | Cushing disease | | | | 1 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | USP48 CL E G H | 84196 | 18533 | ORPHA:96253 | Cushing disease | | | | 1 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | USP8 CL E G H | 9101 | 12631 | ORPHA:96253 | Cushing disease | | | | 7 | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | USP8 CL E G H | 9101 | 12631 | ORPHA:96253 | Cushing disease | | | | 7 | | |
HP:0011731 | HP:0003118 | Increased circulating cortisol level | 1 | ZNRF3 CL E G H | 84133 | 18126 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | | | |
HP:0011731 | HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test | 1 | ZNRF3 CL E G H | 84133 | 18126 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | | | |
HP:0011731 | HP:0011744 | Secondary hypercortisolism | 2 | CL E G H | | | | | | | | | | |
HP:0011731 | HP:0001579 | Primary hypercortisolism | 2 | CDKN1A CL E G H | 1026 | 1784 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 2 | | |
HP:0011731 | HP:0001579 | Primary hypercortisolism | 2 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 102 | | |
HP:0011731 | HP:0025436 | Elevated serum 11-deoxycortisol | 2 | CDKN2A CL E G H | 1029 | 1787 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 289 | | |
HP:0011731 | HP:0001579 | Primary hypercortisolism | 2 | CDKN2B CL E G H | 1030 | 1788 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 1 | | |
HP:0011731 | HP:0001579 | Primary hypercortisolism | 2 | CDKN2C CL E G H | 1031 | 1789 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | | | |
HP:0011731 | HP:0025436 | Elevated serum 11-deoxycortisol | 2 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 88 | | |
HP:0011731 | HP:0025436 | Elevated serum 11-deoxycortisol | 2 | CYP11B1 CL E G H | 1584 | 2591 | OMIM:202010 | Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency | | | | 112 | | |
HP:0011731 | HP:0025436 | Elevated serum 11-deoxycortisol | 2 | CYP11B2 CL E G H | 1585 | 2592 | ORPHA:556030 | Early-onset familial hypoaldosteronism | HP:0040282 - Frequent | | | 73 | | |
HP:0011731 | HP:0001579 | Primary hypercortisolism | 2 | GNAS CL E G H | 2778 | 4392 | OMIM:219080 | ACTH-independent macronodular adrenal hyperplasia | . | | | 101 | | |
HP:0011731 | HP:0001579 | Primary hypercortisolism | 2 | GNAS CL E G H | 2778 | 4392 | ORPHA:562 | McCune-Albright syndrome | HP:0040284 - Very rare | | | 101 | | |
HP:0011731 | HP:0001579 | Primary hypercortisolism | 2 | MEN1 CL E G H | 4221 | 7010 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 462 | | |
HP:0011731 | HP:0001579 | Primary hypercortisolism | 2 | PDE11A CL E G H | 50940 | 8773 | OMIM:610475 | Pigmented nodular adrenocortical disease, primary, 2 | . | | | 13 | | |
HP:0011731 | HP:0001579 | Primary hypercortisolism | 2 | PRKACA CL E G H | 5566 | 9380 | OMIM:615830 | Pigmented nodular adrenocortical disease, primary, 4 | . | | | 2 | | |
HP:0011731 | HP:0025436 | Elevated serum 11-deoxycortisol | 2 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 134 | | |
HP:0011731 | HP:0001579 | Primary hypercortisolism | 2 | PRKAR1A CL E G H | 5573 | 9388 | OMIM:610489 | Pigmented nodular adrenocortical disease, primary, 1 | . | | | 134 | | |
HP:0011731 | HP:0025436 | Elevated serum 11-deoxycortisol | 2 | TERT CL E G H | 7015 | 11730 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 238 | | |
HP:0011731 | HP:0025436 | Elevated serum 11-deoxycortisol | 2 | TP53 CL E G H | 7157 | 11998 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 911 | | |
HP:0011731 | HP:0025436 | Elevated serum 11-deoxycortisol | 2 | ZNRF3 CL E G H | 84133 | 18126 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | | | |